With respect to the tumor-infiltrating lymphocytes (TILs), we found a higher, although non-significant, prevalence in the T-without than in the T-with samples (mean: 30.61%, 95% CI: 9.08–52.13%; mean: 23.83%, 95% CI: 2.19–45.47%, respectively, p = 0.28), potentially mirroring the PD-L1 status within the two groups. The gene discussed is CD274; the disease is neoplasm.